Healwell AI Faces Regulatory Scrutiny Over Revenue Forecasts

Healwell AI Inc. has entered 2026 navigating a complex landscape shaped by regulatory pressure and a fundamental strategic shift. The Ontario Securities Commission (OSC) compelled the company to provide greater detail on its financial projections just before the turn of the year, casting a spotlight on the robustness of its growth narrative as it transitions to a pure-play artificial intelligence firm.

Central to the current investor focus is the company’s dramatic strategic overhaul. To cement its position as a dedicated AI and SaaS provider, Healwell is divesting capital-intensive clinical operations. This includes the sale of clinics to the WELL Health Clinic Network and the disposal of its stake in Mutuo Health Read more...